These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25640284)

  • 1. A Shocking End to the Defibrillator as We Know It: Unmet Needs and the Case for a Stand-Alone Device that Uses Pacing Only to Treat the Risk of Life-Threatening Arrhythmias.
    Gimbel JR
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):655-8. PubMed ID: 25640284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator.
    Ganjehei L; Nazeri A; Massumi A; Razavi M
    Tex Heart Inst J; 2012; 39(4):568-70. PubMed ID: 22949781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance.
    Tjong FV; Brouwer TF; Smeding L; Kooiman KM; de Groot JR; Ligon D; Sanghera R; Schalij MJ; Wilde AA; Knops RE
    Europace; 2016 Nov; 18(11):1740-1747. PubMed ID: 26941338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate shock despite successful termination of supraventricular tachycardia by antitachycardia pacing during charging.
    Bernier M; Essebag V
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):e81-3. PubMed ID: 20230474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators.
    Groh WJ; Foreman LD; Zipes DP
    Am Fam Physician; 1998 Jan; 57(2):297-307, 310-2. PubMed ID: 9456993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillator.
    Mickleborough LL
    Adv Card Surg; 1994; 5():209-30. PubMed ID: 8118593
    [No Abstract]   [Full Text] [Related]  

  • 7. Unexpected Shocks From a Subcutaneous Implantable Cardioverter-Defibrillator Despite Attempted Reprogramming and Magnet Use: A Case Report.
    McFaul CM; Lombaard S; Arora V; Van Cleve WC; Rooke GA; Prutkin JM
    A A Pract; 2020 Apr; 14(6):e01178. PubMed ID: 32224692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
    [No Abstract]   [Full Text] [Related]  

  • 9. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
    Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of device therapy for ventricular arrhythmias.
    Holley LK
    Heart Lung Circ; 2007 Jun; 16(3):162-9. PubMed ID: 17446124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"?
    Jackson LR; Daubert JP; Thomas KL
    Prog Cardiovasc Dis; 2012; 54(4):372-8. PubMed ID: 22226007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular implantable electronic devices in athletes.
    Do R; Patton KK
    Cardiovasc Ther; 2010 Oct; 28(5):327-36. PubMed ID: 20553287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and cause of anxiety in patients with an implantable cardioverter-defibrillator: a longitudinal two-year follow-up.
    Crössmann A; Pauli P; Dengler W; Kühlkamp V; Wiedemann G
    Heart Lung; 2007; 36(2):87-95. PubMed ID: 17362789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hyperkalaemia on cardiac rhythm devices.
    Barold SS; Herweg B
    Europace; 2014 Apr; 16(4):467-76. PubMed ID: 24465006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillators: a guide for clinicians.
    Davidson T; VanRiper S; Harper P; Wenk A
    Heart Lung; 1994; 23(3):205-15; quiz 216-7. PubMed ID: 8039991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter defibrillator therapy in athletes.
    Heidbüchel H
    Cardiol Clin; 2007 Aug; 25(3):467-82, vii. PubMed ID: 17961801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Back to the past or on to the future?
    Zipes DP
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):659; discussion 659. PubMed ID: 25753303
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation of geomagnetic activity with implantable cardioverter defibrillator shocks and antitachycardia pacing.
    Ebrille E; Konecny T; Konecny D; Spacek R; Jones P; Ambroz P; DeSimone CV; Powell BD; Hayes DL; Friedman PA; Asirvatham SJ
    Mayo Clin Proc; 2015 Feb; 90(2):202-8. PubMed ID: 25659238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.